Moore Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
VCM
VPM
Moore Capital Management's ZBH Position: Q1 2026 in Review
Moore Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 126,806 shares — an estimated $11.4M sold.
Moore Capital Management first reported a position in ZBH in Q3 2014 and held it in 15 quarters. The position peaked at $22.5M in Q3 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Moore Capital Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Moore Capital Management sold 126,806 Zimmer Biomet shares in Q1 2026, an estimated $11.4M.
- Moore Capital Management first reported a position in Zimmer Biomet in Q3 2014 and held it in 15 quarters.
- Moore Capital Management's Zimmer Biomet position peaked at $22.5M in Q3 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.